Spotlight report on molecular testing in advanced lung cancer

Spotlight report on molecular testing in advanced lung cancer
HQIP 9 January 2020

• Results of the first national study investigating the efficacy and outcomes of molecular testing in patients with advanced non-small-cell lung cancer (NSCLC) in England. In total 60 trusts provided data on 1,157 patients.